How did the Human Genome Project contribute to personalized medicine?

Created from Britannica articles using AI. AI can make mistakes, so verify using Britannica articles.

The Human Genome Project (HGP) was a foundational catalyst for personalized medicine, a field that tailors disease prevention, diagnosis, and treatment to an individual's unique genetic profile. By elucidating the sequence of more than three billion base pairs in the human genome, the project provided the essential data necessary to understand how genetic variations influence health and drug responses.12

Key contributions include:

  • Disease Association: The HGP enabled researchers to identify genes associated with both rare and common diseases. By utilizing genome-wide association studies, scientists can now link specific genetic variants to disease risk, allowing for more accurate and objective diagnoses, sometimes even before clinical symptoms appear.12
  • Pharmacogenomics: The project advanced the study of pharmacogenomics, which examines how an individual's genetic makeup affects their response to medications. This helps physicians predict which drugs will be most effective and identify patients at risk for severe side effects.23
  • Targeted Therapy: The genomic data provided by the HGP facilitated the development of targeted therapies, which use drugs to attack specific molecular anomalies in cancer cells while sparing healthy tissue.24

Ultimately, the HGP shifted medicine from a "one-size-fits-all" strategy toward a model where healthcare providers can deliver more effective, individualized care based on a patient's entire genome sequence.12